Literature DB >> 23287577

Respiratory motion correction in oncologic PET using T1-weighted MR imaging on a simultaneous whole-body PET/MR system.

Christian Würslin1, Holger Schmidt, Petros Martirosian, Cornelia Brendle, Andreas Boss, Nina F Schwenzer, Lars Stegger.   

Abstract

UNLABELLED: Hybrid PET/MR combines the exceptional molecular sensitivity of PET with the high resolution and versatility of MR imaging. Simultaneous data acquisition additionally promises the use of MR to enhance the quality of PET images, for example, by respiratory motion correction. This advantage is especially relevant in thoracic and abdominal areas to improve the visibility of small lesions with low radiotracer uptake and to enhance uptake quantification. In this work, the applicability and performance of an MR-based method of respiratory motion correction for PET tumor imaging was evaluated in phantom and patient studies.
METHODS: PET list-mode data from a motion phantom with (22)Na point sources and 5 patients with tumor manifestations in the thorax and upper abdomen were acquired on a simultaneous hybrid PET/MR system. During the first 3 min of a 5-min PET scan, the respiration-induced tissue deformation in the PET field of view was recorded using a sagittal 2-dimensional multislice gradient echo MR sequence. MR navigator data to measure the location of the diaphragm were acquired throughout the PET scan. Respiration-gated PET data were coregistered using the MR-derived motion fields to obtain a single motion-corrected PET dataset. The effect of motion correction on tumor visibility, delineation, and radiotracer uptake quantification was analyzed with respect to uncorrected and gated images.
RESULTS: Image quality in terms of lesion delineation and uptake quantification was significantly improved compared with uncorrected images for both phantom and patient data. In patients, in head-feet line profiles of 14 manifestations, the slope became steeper by 66.7% (P = 0.001) and full width at half maximum was reduced by 20.6% (P = 0.001). The mean increase in maximum standardized uptake value, lesion-to-background ratio (contrast), and signal-to-noise ratio was 28.1% (P = 0.001), 24.7% (P = 0.001), and 27.3% (P = 0.003), respectively. Lesion volume was reduced by an average of 26.5% (P = 0.002). As opposed to the gated images, no increase in background noise was observed. However, motion correction performed worse than gating in terms of contrast (-11.3%, P = 0.002), maximum standardized uptake value (-10.7%, P = 0.003), and slope steepness (-19.3%, P = 0.001).
CONCLUSION: The proposed method for MR-based respiratory motion correction of PET data proved feasible and effective. The short examination time and convenience (no additional equipment required) of the method allow for easy integration into clinical routine imaging. Performance compared with gating procedures can be further improved using list-mode-based motion correction.

Entities:  

Mesh:

Year:  2013        PMID: 23287577     DOI: 10.2967/jnumed.112.105296

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  36 in total

1.  Improvements in PET Image Quality in Time of Flight (TOF) Simultaneous PET/MRI.

Authors:  Ryogo Minamimoto; Craig Levin; Mehran Jamali; Dawn Holley; Amir Barkhodari; Greg Zaharchuk; Andrei Iagaru
Journal:  Mol Imaging Biol       Date:  2016-10       Impact factor: 3.488

2.  Accelerated acquisition of tagged MRI for cardiac motion correction in simultaneous PET-MR: phantom and patient studies.

Authors:  Chuan Huang; Yoann Petibon; Jinsong Ouyang; Timothy G Reese; Mark A Ahlman; David A Bluemke; Georges El Fakhri
Journal:  Med Phys       Date:  2015-02       Impact factor: 4.071

Review 3.  Motion correction options in PET/MRI.

Authors:  Ciprian Catana
Journal:  Semin Nucl Med       Date:  2015-05       Impact factor: 4.446

Review 4.  Quantitative Rodent Brain Receptor Imaging.

Authors:  Kristina Herfert; Julia G Mannheim; Laura Kuebler; Sabina Marciano; Mario Amend; Christoph Parl; Hanna Napieczynska; Florian M Maier; Salvador Castaneda Vega; Bernd J Pichler
Journal:  Mol Imaging Biol       Date:  2020-04       Impact factor: 3.488

5.  Higher-order singular value decomposition-based lung parcellation for breathing motion management.

Authors:  Samadrita Roy Chowdhury; Joyita Dutta
Journal:  J Med Imaging (Bellingham)       Date:  2019-05-03

Review 6.  Combined PET/MR: Where are we now? Summary report of the second international workshop on PET/MR imaging April 8-12, 2013, Tubingen, Germany.

Authors:  Dale L Bailey; Henryk Barthel; Bettina Beuthin-Baumann; Thomas Beyer; Sotirios Bisdas; Ronald Boellaard; Johannes Czernin; Alexander Drzezga; Ulrike Ernemann; Christiane Franzius; Brigitte Gückel; Rupert Handgretinger; Markus Hartenbach; Dirk Hellwig; Helen Nadel; Stephan G Nekolla; Thomas Pfluger; Bernd J Pichler; Harald H Quick; Osama Sabri; Bernhard Sattler; Jürgen Schäfer; Fritz Schick; Barry A Siegel; Heinz P Schlemmer; Nina F Schwenzer; Jörg van den Hoff; Patrick Veit-Haibach; Hans F Wehrl
Journal:  Mol Imaging Biol       Date:  2014-06       Impact factor: 3.488

7.  A pilot study in epilepsy patients using simultaneous PET/MR.

Authors:  Yu-Shin Ding; Bang-Bin Chen; Christopher Glielmi; Kent Friedman; Orrin Devinsky
Journal:  Am J Nucl Med Mol Imaging       Date:  2014-08-15

Review 8.  The Use of Anatomical Information for Molecular Image Reconstruction Algorithms: Attenuation/Scatter Correction, Motion Compensation, and Noise Reduction.

Authors:  Se Young Chun
Journal:  Nucl Med Mol Imaging       Date:  2016-02-11

Review 9.  PET/MRI: Technical Challenges and Recent Advances.

Authors:  Jin Ho Jung; Yong Choi; Ki Chun Im
Journal:  Nucl Med Mol Imaging       Date:  2016-01-26

10.  Concurrent Respiratory Motion Correction of Abdominal PET and Dynamic Contrast-Enhanced-MRI Using a Compressed Sensing Approach.

Authors:  Niccolo Fuin; Onofrio A Catalano; Michele Scipioni; Lisanne P W Canjels; David Izquierdo-Garcia; Stefano Pedemonte; Ciprian Catana
Journal:  J Nucl Med       Date:  2018-01-25       Impact factor: 10.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.